Video

Heated Intraperitoneal Chemotherapy (HIPEC) for Rare, Aggressive Cancers at Penn Medicine

HIPEC is one of the most innovative treatments available today for complex cancers. Associate Professor of Surgery at the Hospital of the University of Pennsylvania and a surgical oncologist, Dr. Giorgos Karakousis specializes in heated ...

Video

Dr. Ronny Drapkin Reviews Advances in Ovarian Cancer Treatment Research

Among the top ovarian cancer researchers in the country, Penn Medicine Gynecologic Pathologist Ronny Drapkin, MD, PhD, is a passionate advocate of pioneering scientific research to detect and treat ovarian cancer.

Video

A Seat at the Table: Removing Barriers and Bias for Women in Oncology | Penn Medicine

In Fall 2019, Penn Medicine’s Abramson Cancer Center hosted its inaugural Women in Oncology event, A Seat at the Table.

Video

Clinical Trials and Research at the Penn Brain Tumor Center

The Penn Brain Tumor Center offers patients access to innovative advances in treatment -- including immunotherapy -- through personalized clinical trials.

Video

Why Are Brain Tumor Second Opinions Important? — the Penn Brain Tumor Center

As M. Sean Grady, Chairman, Department of Neurosurgery, explains, when patients are faced with a malignant brain tumor, a second opinion from the specialists at the Penn Brain Tumor Center can confirm or clarify the initial diagnosis and, ...

Video

How a Neuro-Oncology Nurse Navigator Supports Patients During Brain Tumor Treatment | The Penn Brain Tumor Center

With specialized training and knowledge of cancer diagnoses, treatments and health system operations, Penn Neuro-Onc Nurse Navigators act as a patient’s primary contact during their course of care.

News

BCMA-Targeted Immunotherapy Can Lead to Durable Responses in Multiple Myeloma

Randomized trial shows benefit of belantamab mafodotin in relapsed/refractory patients

News

Penn Clinical Research Roundup: Breast Cancer

Penn faculty, physician scientists and medical trainees frequently contribute to research in the fields of medical and surgical oncology. Both Penn and the Abramson Cancer Center have created a culture deeply rooted in research, academic ...

News

Blood Test Identifies More Treatable Cancer Mutations Than Tissue Biopsy Alone

Researchers from the Abramson Cancer Center of the University of Pennsylvania found that they could identify significantly more mutations through liquid biopsy instead of a solid tissue biopsy alone.

Releasing the Brakes: Potential New Methods for Duchenne Muscular Dystrophy Therapies Discovered

Machine Learning Identifies Personalized Brain Networks in Children

Results from a new study suggest that Bmal1 gene is not an essential regulator of circadian rhythms

DNA Misfolding in White Blood Cells Increases Risk for Type 1 Diabetes

Fewer Steroids No Plasma Exchange A Change in Treatment for Vasculitis

Penn Medicine Researchers Illuminate Racial Disparity in U.S. Acne Treatment